Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) TheSUBWAY Stock Trader Pick of the Day
This morning we are looking at Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) for a trade. IDEV is up nice on news this morning in a bad tape:
Our Stochastics are in excellent position:
Our daily chart is looking very attractive for a trade today:
Our 15 Minute is flat until today, so we are not looking to stay in Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV):
Though we are seeing nice upward momentum in Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV), so we will not exit until we are stopped out with a trailing stop somewhere around 2% this morning:
TheSubway.com acknowledges and thanks the principles of www.philsgang.com site for their permission in allowing us the use and demonstration of the their Phil’s X-1 and Phil’s X-2 charting software.
Full disclosure: Long at time of writing - Disclosure of Conflicts of Interest
All material herein was prepared by CRG Partners, Inc. (CRGP) based upon information believed to be reliable. The information contained herein is not guaranteed by CRGP to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. CRGP is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.thesubway.com or mentioned herein. CRGP may have been compensated by third party shareholders with shares or with cash from the company on behalf of one or more of the companies mentioned in this opinion. CRGP’s Licensors, affiliates, officers, directors and employees may own shares and intend to buy and sell additional shares of the company mentioned herein and may profit in the event those shares rise in value.





























